Exports to S. Korea up 63%

South Korea was Israel's fastest growing destination market in August, with non-diamond goods exports growing 63% since the same month last year to $64 million, the Israel Exports Institute said Wednesday.

By DANIEL KENNEMER
October 5, 2006 07:35

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

South Korea was Israel's fastest growing destination market in August, with non-diamond goods exports growing 63% since the same month last year to $64 million, the Israel Exports Institute said Wednesday. Mexico came in second, receiving $24m. in Israeli goods, 55% more than last August, while exports to Canada rose 40% to $41m. Exports to Brazil suffered the biggest drop, sliding 38% to $34m. The US remained Israel's largest destination market, receiving $871m. in August, up 15% from the same month last year.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS